These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 12640446)

  • 41. Cerebral hemorrhage after passive anti-Abeta immunotherapy.
    Pfeifer M; Boncristiano S; Bondolfi L; Stalder A; Deller T; Staufenbiel M; Mathews PM; Jucker M
    Science; 2002 Nov; 298(5597):1379. PubMed ID: 12434053
    [No Abstract]   [Full Text] [Related]  

  • 42. [Aβ immunotherapy for Alzheimer's disease].
    Sakai K; Yamada M
    Brain Nerve; 2013 Apr; 65(4):461-8. PubMed ID: 23568994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. I32E and V36K double mutation in beta2-sheet abrogates amyloid beta peptide toxicity.
    Subramanian S; Mishra PK; Bandopadhyay D
    Indian J Exp Biol; 2010 Nov; 48(11):1098-102. PubMed ID: 21117449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease.
    Ferrer I; Boada Rovira M; Sánchez Guerra ML; Rey MJ; Costa-Jussá F
    Brain Pathol; 2004 Jan; 14(1):11-20. PubMed ID: 14997933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.
    McGeer PL; McGeer EG
    Acta Neuropathol; 2013 Oct; 126(4):479-97. PubMed ID: 24052108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.
    Orgogozo JM; Gilman S; Dartigues JF; Laurent B; Puel M; Kirby LC; Jouanny P; Dubois B; Eisner L; Flitman S; Michel BF; Boada M; Frank A; Hock C
    Neurology; 2003 Jul; 61(1):46-54. PubMed ID: 12847155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. patial pattern analysis of beta-amyloid (A beta) deposits in Alzheimer disease by linear regression.
    Armstrong RA; Wood L
    Alzheimer Dis Assoc Disord; 1996; 10(1):40-5. PubMed ID: 8919495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of active Aβ immunotherapy on neurons in human Alzheimer's disease.
    Paquet C; Amin J; Mouton-Liger F; Nasser M; Love S; Gray F; Pickering RM; Nicoll JA; Holmes C; Hugon J; Boche D
    J Pathol; 2015 Apr; 235(5):721-30. PubMed ID: 25430817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abeta immunization: moving Abeta peptide from brain to blood.
    Lee VM
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):8931-2. PubMed ID: 11481462
    [No Abstract]   [Full Text] [Related]  

  • 50. Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease.
    Monsonego A; Imitola J; Petrovic S; Zota V; Nemirovsky A; Baron R; Fisher Y; Owens T; Weiner HL
    Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5048-53. PubMed ID: 16549802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Alzheimer vaccine].
    Tabira T
    Nihon Rinsho; 2008 Oct; 66(10):2008-12. PubMed ID: 18939505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis.
    Patton RL; Kalback WM; Esh CL; Kokjohn TA; Van Vickle GD; Luehrs DC; Kuo YM; Lopez J; Brune D; Ferrer I; Masliah E; Newel AJ; Beach TG; Castaño EM; Roher AE
    Am J Pathol; 2006 Sep; 169(3):1048-63. PubMed ID: 16936277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipient.
    Roher AE; Maarouf CL; Daugs ID; Kokjohn TA; Hunter JM; Sabbagh MN; Beach TG
    J Alzheimers Dis; 2011; 24(2):315-25. PubMed ID: 21263194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aβ vaccination in combination with behavioral enrichment in aged beagles: effects on cognition, Aβ, and microhemorrhages.
    Davis PR; Giannini G; Rudolph K; Calloway N; Royer CM; Beckett TL; Murphy MP; Bresch F; Pagani D; Platt T; Wang X; Donovan AS; Sudduth TL; Lou W; Abner E; Kryscio R; Wilcock DM; Barrett EG; Head E
    Neurobiol Aging; 2017 Jan; 49():86-99. PubMed ID: 27776266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease.
    Monsonego A; Zota V; Karni A; Krieger JI; Bar-Or A; Bitan G; Budson AE; Sperling R; Selkoe DJ; Weiner HL
    J Clin Invest; 2003 Aug; 112(3):415-22. PubMed ID: 12897209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral amyloid angiopathy and microhemorrhages after amyloid beta vaccination: case report and brief review.
    Uro-Coste E; Russano de Paiva G; Guilbeau-Frugier C; Sastre N; Ousset PJ; da Silva NA; Lavialle-Guillotreau V; Vellas B; Delisle MB
    Clin Neuropathol; 2010; 29(4):209-16. PubMed ID: 20569670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Refining an Alzheimer's vaccine to avoid an inflammatory response.
    Brown ME; DaSilva KA; McLaurin J
    Expert Opin Biol Ther; 2005 Jun; 5(6):809-16. PubMed ID: 15952911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T-cells in Alzheimer's disease.
    Town T; Tan J; Flavell RA; Mullan M
    Neuromolecular Med; 2005; 7(3):255-64. PubMed ID: 16247185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downregulated apoptosis and autophagy after anti-Aβ immunotherapy in Alzheimer's disease.
    Paquet C; Nicoll JA; Love S; Mouton-Liger F; Holmes C; Hugon J; Boche D
    Brain Pathol; 2018 Sep; 28(5):603-610. PubMed ID: 29027727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Murine models of Alzheimer's disease and their use in developing immunotherapies.
    Wisniewski T; Sigurdsson EM
    Biochim Biophys Acta; 2010 Oct; 1802(10):847-59. PubMed ID: 20471477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.